Design and synthesis of 4-morpholino-6-(1, 2, 3, 6-tetrahydropyridin-4-yl)-N-(3, 4, 5-trimethoxyphenyl)-1, 3, 5-triazin-2-amine analogues as tubulin polymerization inhibitors. Issue 16 (15th August 2017)
- Record Type:
- Journal Article
- Title:
- Design and synthesis of 4-morpholino-6-(1, 2, 3, 6-tetrahydropyridin-4-yl)-N-(3, 4, 5-trimethoxyphenyl)-1, 3, 5-triazin-2-amine analogues as tubulin polymerization inhibitors. Issue 16 (15th August 2017)
- Main Title:
- Design and synthesis of 4-morpholino-6-(1, 2, 3, 6-tetrahydropyridin-4-yl)-N-(3, 4, 5-trimethoxyphenyl)-1, 3, 5-triazin-2-amine analogues as tubulin polymerization inhibitors
- Authors:
- Narva, Suresh
Chitti, Surendar
Amaroju, Suresh
Bhattacharjee, Debanjan
Rao, Bala Bhaskara
Jain, Nishant
Alvala, Mallika
Sekhar, Kondapalli Venkata Gowri Chandra - Abstract:
- Graphical abstract: Highlights: New 1, 3, 5-triazine analogues were synthesized and evaluated for anticancer activity. Cytotoxic evaluation carried against HeLa, HepG2, A549 and MCF-7 cell lines. 8j showed strong inhibitory effect (IC50 = 9.6 μM) against HepG2 cell line. 8j was found to arrest the cells in the G2/M phase and disrupt the microtubule. 8j binds to nocodazole binding site of tubulin with a binding affinity of −7.949. Abstract: A series of thirty-seven 1, 3, 5-triazine analogues have been synthesized, characterized and evaluated for their antiproliferative activity against a panel of four different human cancer cell lines such as HeLa, HepG2, A549 and MCF-7. Most of the 1, 3, 5-triazine analogues exhibited promising antiproliferative activity against tested cancer cell lines. Among all the synthesized compounds, 8j showed potent activity against the cancer cell lines such as HeLa, HepG2, A549 and MCF-7 with IC50 12.3 ± 0.8, 9.6 ± 0.4, 10.5 ± 1.0 and 11.7 ± 0.5 μM respectively.8j was taken up for elaborate biological studies and the cells in the cell cycle were arrested in G2/M phase. In addition, 8j was examined for its effect on the microtubule system with a tubulin polymerization assay, immunofluorescence.8j showed remarkable inhibition of tubulin polymerization. Molecular docking studies were also carried out to understand the binding pattern. The studies suggested that8j has a good binding affinity of −7.949 towards nocodazole binding site of tubulin whileGraphical abstract: Highlights: New 1, 3, 5-triazine analogues were synthesized and evaluated for anticancer activity. Cytotoxic evaluation carried against HeLa, HepG2, A549 and MCF-7 cell lines. 8j showed strong inhibitory effect (IC50 = 9.6 μM) against HepG2 cell line. 8j was found to arrest the cells in the G2/M phase and disrupt the microtubule. 8j binds to nocodazole binding site of tubulin with a binding affinity of −7.949. Abstract: A series of thirty-seven 1, 3, 5-triazine analogues have been synthesized, characterized and evaluated for their antiproliferative activity against a panel of four different human cancer cell lines such as HeLa, HepG2, A549 and MCF-7. Most of the 1, 3, 5-triazine analogues exhibited promising antiproliferative activity against tested cancer cell lines. Among all the synthesized compounds, 8j showed potent activity against the cancer cell lines such as HeLa, HepG2, A549 and MCF-7 with IC50 12.3 ± 0.8, 9.6 ± 0.4, 10.5 ± 1.0 and 11.7 ± 0.5 μM respectively.8j was taken up for elaborate biological studies and the cells in the cell cycle were arrested in G2/M phase. In addition, 8j was examined for its effect on the microtubule system with a tubulin polymerization assay, immunofluorescence.8j showed remarkable inhibition of tubulin polymerization. Molecular docking studies were also carried out to understand the binding pattern. The studies suggested that8j has a good binding affinity of −7.949 towards nocodazole binding site of tubulin while nocodazole has −7.462. … (more)
- Is Part Of:
- Bioorganic & medicinal chemistry letters. Volume 27:Issue 16(2017)
- Journal:
- Bioorganic & medicinal chemistry letters
- Issue:
- Volume 27:Issue 16(2017)
- Issue Display:
- Volume 27, Issue 16 (2017)
- Year:
- 2017
- Volume:
- 27
- Issue:
- 16
- Issue Sort Value:
- 2017-0027-0016-0000
- Page Start:
- 3794
- Page End:
- 3801
- Publication Date:
- 2017-08-15
- Subjects:
- 1, 3, 5-Triazine -- Morpholine -- Antiproliferative activity -- Tubulin polymerization -- Molecular docking study
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
572 - Journal URLs:
- http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description ↗
http://www.sciencedirect.com/science/journal/0960894X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmcl.2017.06.060 ↗
- Languages:
- English
- ISSNs:
- 0960-894X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.330000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10943.xml